Stay updated on HexaBody-DR5/DR5 Safety Clinical Trial
Sign up to get notified when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.

Latest updates to the HexaBody-DR5/DR5 Safety Clinical Trial page
- ChecktodayChange DetectedDifference0.5%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed trial information regarding GEN1029, including its purpose, trial structure, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference16%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.9%
- Check37 days agoChange DetectedThe page has been updated to include information on Renal Cell Carcinoma and has been revised to version 2.14.3, while references to Pancreatic Cancer and the previous version 2.14.2 have been removed.SummaryDifference0.2%
- Check44 days agoChange DetectedDifference0.3%
Stay in the know with updates to HexaBody-DR5/DR5 Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.